Elevated SERPINE1 expression serves as a biomarker in various solid tumors, including breast cancer, ovarian cancer, colon cancer, and non-small cell lung cancer, and it is regarded as a possible therapeutic target [81]. Here, SERPINE1 is linked to breast carcinoma.